Biostar Pharma Cash Flow - Annual (NASDAQ:BSPM)

Add to My Stocks
$1.88 $0.06 (3.3%) BSPM stock closing price Sep 18, 2018 (Closing)

For analyzing any company like Biostar Pharma from an investment perspective, its important to check the cash flow statement. While its important to look at the Biostar Pharma debt position, the cash flow statement becomes equally important because public companies use accrual accounting. For example, if a company sells a product which gets counted as Biostar Pharma revenue but does not convert to cash because it does not receive payment in the same quarter, it affects the cash position for that period. Items like capital purchases, bank loan payments etc. which have a direct impact on the cash position of a company come out through the statemement of cash flows and help an investor who undertakes the Biostar Pharma stock analysis. Biostar Pharma generated $4.91M cash from operating activities in 2016. Biostar Pharma saw a outflow of $-6.37M from investing activities for 2016.

View details of Biostar Pharma cash flows for latest & last 10 financial years
show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec201620152014201320122011201020092008
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow1.14M2.32M3.08M2.78M1.82M----
Net Increase (Decrease) in Assets Liabilities7.3M5.34M-6.07M2.23M6.3M-8.52M-6.03M-6.82M-8.11M
Cash From (used in) Discontinued Operations---------
Other Adjustments Net2.16M23.32M1.45M3.07M8.28M4.23M-1.38M-
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment--0.05M-2.86M-0.98M-0.01M-0.11M-1.46M-1.04M-0.05M
Acquisition Disposition of Subsidiaires-----0.82M-4.03M---
Increase (Decrease) in Investments---------
Other Cash Inflow (Outflow) from Investment Activities-6.37M-7.31M-6.01M-3.22M-16.45M-2.19M-7.07M-2.48M-0.27M
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares1.68M-3.86M----5.67M-
Issuance (Repayment) of Debt Securities---------
Increase (Decrease) in Bank & Other Borrowings-0.27M-0.16M3.09M-6.45M5.54M----0.54M
Payment of Dividends & Other Cash Distributions---------
Other Cash from (used by) Financing Activities---------
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash---------
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year-1.68M-1.75M16.97M13.21M8.57M-2.28M
Cash & Equivalents at Year End--1.68M-1.75M16.97M13.21M8.57M-
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Biostar Pharma stock price history provides insight into historical stock price fluctuations, and Biostar Pharma stock comparison chart enables peer comparison. Some of the key terms used in the statement of cash flows are:

  • Biostar Pharma had a Net Change in Cash and Cash Equivalents of $- for the latest year 2016. If a firm is able to grow its cash, it is considered to be a positive signal and could lead to a jump in the Biostar Pharma stock price, albeit too much cash on hand can imply the company has no or limited avenues for growth in which to invest this cash.
  • Cash Flow from operating activities: Biostar Pharma reported a positive operating cash flow of $4.91M for 2016 and has seen a decrease from the previous year. Operating cash flow comes from main business activities. Investors look for positive cash flow from recurring operating activities.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc., and was $-6.37M for BSPM in last 2016 report.
  • Cash flow from financing activities shows the flow of cash between Biostar Pharma and its owners and creditors and was $1.41M for 2016. Financing activities allow a company to raise capital, and repay bondholders.

Key Financial Ratios For Biostar Pharma Cash Flow